• Home
  • SAS DELPHARM INDUSTRIE

SAS DELPHARM INDUSTRIE

About SAS DELPHARM INDUSTRIE

Delpharm is a worldwide leader in contract development and manufacturing of medicines for pharmaceutical companies. The company manufactures annually more than one billion units in its manufacturing and development sites providing the majority of available dosage forms on the market: tablets, injectable vials / ampoules / prefilled syringes, freeze dry, suspensions, solutions, ointments and soft gels.The company employs more than 6,500 people and has achieved in 2022 a revenue of €1 billion.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • FR
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
Contract Service
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Americas 2025

Pennsylvania Convention Center, Philadelphia
20 May 2025 - 22 May 2025
View Exhibitor Profile

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
View Exhibitor Profile

Products from SAS DELPHARM INDUSTRIE (27)

  • Prefilled Syringes

    Product Prefilled Syringes

    Delpharm group offers pharmaceutical services which includes glass prefilled syringes.  Capsules. Contact us for more information.
  • Tablets naked

    Product Tablets naked

    Delpharm group offers pharmaceutical products & services which includes tablets naked. It belongs to solid forms category. Semisolids: gelstablets nakedsyrups. Specialties: highly active. Contact us for more information.
  • Biotech

    Product Biotech

    - Cell culture
    - Diagnostics
  • Specialities

    Product Specialities

    - High potent (hormones/oncology)
    - Hormonal gels
    - Hormonal liquids
    - Impregnated dressings
    - Bottle filling for tablets
  • Capsules

    Product Capsules

    Delpharm group offers pharmaceutical services which includes capsules. It belongs to solid forms category. Capsules. Contact us for more information.
  • Sparkling

    Product Sparkling

    Delpharm group offers pharmaceutical services which includes sparkling. It belongs to solid forms category. Semisolids: ointment sparkling sachets. Specialties: biotechnology. Contact us for more information.
  • Coated tablets

    Product Coated tablets

    Delpharm group offers pharmaceutical services which includes coated tablets. It belongs to solid forms category. Semisolids: creamscoated tabletsdrops. Specialties: cytotoxic. Contact us for more information.
  • Sachets

    Product Sachets

    Delpharm group offers pharmaceutical services which includes sachets. It belongs to solid forms category. Sachets. Contact us for more information.
  • Film-coated tablets

    Product Film-coated tablets

    Delpharm group offers pharmaceutical services which includes film-coated tablets. It belongs to solid forms category. Semisolids: suppositories film-coated tablets bulbs. Specialties: sterile injectable. Contact us for more information.
  • Pellets

    Product Pellets

    Delpharm group offers pharmaceutical services which includes pellets. It belongs to solid forms category. Pellets injectables specialties: barium products. Contact us for more information.
  • Freeze-drying

    Product Freeze-drying

    Freeze-Drying is now available at Delpharm Saint-Rémy. 
  • New product development

    Product New product development

    Delpharm group offers pharmaceutical services which includes new product development. It belongs to services and commitments category. It can support your development of sourcing the active ingredients in the product registration and monitoring of the file with the health authorities in providing you with ...
show all 27 products

SAS DELPHARM INDUSTRIE Resources (2)

  • GSK agrees to sell its Poznań manufacturing site to Delpharm.

    News GSK agrees to sell its Poznań manufacturing site to Delpharm.

    Poznań, Poland, Thursday 15 October 2020 –GSK and Delpharm announced today they have entered into an agreement under which Delpharm will acquire GSK’s Poznań manufacturing facility in Poland.
    21 Jun 2021
  • Delpharm Overview

    Brochure Delpharm Overview

    Delpharm is a European leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 12 manufacturing plants (nine in France, two in Italy and one in Belgium) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc. Delpharm generates €500m in turnover and is wholly-owned by its management. For more information, visit our website: http://www.delpharm.com/